Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Most commercially insured patients live with chronic conditions

Most commercially insured patients live with chronic conditions

Aging brains struggle to recycle synaptic proteins

Aging brains struggle to recycle synaptic proteins

Researchers uncover a new cellular process linked to healthy aging

Researchers uncover a new cellular process linked to healthy aging

Distinct tau chemical signatures redefine diagnosis across neurodegenerative diseases

Distinct tau chemical signatures redefine diagnosis across neurodegenerative diseases

Hippocampus reorganizes memories to anticipate future outcomes, study finds

Hippocampus reorganizes memories to anticipate future outcomes, study finds

Research uncovers why certain brain cells are more resilient to tau protein buildup

Research uncovers why certain brain cells are more resilient to tau protein buildup

Study uncovers how the brain's 'memory replay' process is impaired in Alzheimer's disease

Study uncovers how the brain's 'memory replay' process is impaired in Alzheimer's disease

People with cerebral amyloid angiopathy more likely to develop dementia

People with cerebral amyloid angiopathy more likely to develop dementia

Older adults' driving habits may provide early warning signs of cognitive decline or dementia

Older adults' driving habits may provide early warning signs of cognitive decline or dementia

Combination therapy improves cognition in Alzheimer’s models

Combination therapy improves cognition in Alzheimer’s models

Brain protein CUL5 protects neurons by clearing toxic tau clumps

Brain protein CUL5 protects neurons by clearing toxic tau clumps

New research initiative aims to develop retinal screening tool for Alzheimer's

New research initiative aims to develop retinal screening tool for Alzheimer's

CTE should be recognized as new cause of dementia, study suggests

CTE should be recognized as new cause of dementia, study suggests

KAIST proposes novel strategy for multifactorial Alzheimer's treatment

KAIST proposes novel strategy for multifactorial Alzheimer's treatment

New atlas of brain lysosomes sheds light on neurodegenerative disorders

New atlas of brain lysosomes sheds light on neurodegenerative disorders

Menopause associated with reduced brain volume and increased anxiety symptoms

Menopause associated with reduced brain volume and increased anxiety symptoms

Evidence links gut microbiome changes to Alzheimer’s progression

Evidence links gut microbiome changes to Alzheimer’s progression

Selective inhibition of cPLA2 shows promise against Alzheimer's-related brain inflammation

Selective inhibition of cPLA2 shows promise against Alzheimer's-related brain inflammation

Genetic study establishes causal link between obesity and cognitive decline

Genetic study establishes causal link between obesity and cognitive decline

Brain complexity declines in Alzheimer's disease

Brain complexity declines in Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.